The global intravenous immunoglobin market size is expected to reach USD 16.89 Billion in 2028 and register a CAGR of 6.4%, according to the latest report by Reports and Data. Key factors such as rising prevalence of geriatric population and increasing incidence of autoimmune diseases like hypogammaglobulinemia and chronic inflammatory demyelinating polyneuropathy are driving global market revenue growth.

Immunoglobulins are proteins that are produced in the blood plasma to defend the body by binding itself to particular antigens. Intravenous Immunoglobulins are mostly administered through intravenous routes as most people receive immunoglobulins in hospital settings. Increasing prevalence of lifestyle-associated diseases such as antibody deficiency diseases, obesity, rising adoption of sedentary lifestyle, unhealthy eating habits, high consumption of alcohol, sugar, and salts are key factors boosting global market growth. In addition, rising demand for IVIG therapies for treating immunodeficiency diseases like primary and acquired immunodeficiency diseases, advancements in plasma purification methods, and increasing investments in research and development activities by manufacturers are boosting global market growth.

However, factors such as high costs of immunoglobin therapies and uncertain supply, stringent government regulations for usage of intravenous immunoglobin products, and risk of side effects are expected to hamper overall growth of the intravenous immunoglobin market.

Get a sample of the report @  

The report provides a complete coverage of the recent mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others. To offer a clear understanding of the scope of the industry, competitive landscape and different progressive aspects are studied extensively in the report.

Key companies operating in the global market and profiled in the report include:

Omrix Biopharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd., Behring GmbH, Option Care Enterprises, Inc., BioScrip, Inc, ADMA Biologics, Inc., CSL Ltd., Baxter International Inc., Kedrion Biopharma Inc., Grifols S.A, LFB group, Octapharma AG, China Biologics Products, Inc., Biotest AG, and Takeda Pharmaceuticals are some key companies operating in the global intravenous immunoglobin market.

The report further offers insights into company overviews, business landscape, production and manufacturing capacity, product portfolio, financial standing, global market position, gross profit margins, SWOT analysis and Porter’s Five Forces analysis for each company. The report also covers feasibility analysis and investment return analysis to offer deeper insights into market landscape and industrial chain.

Intravenous Immunoglobin (IVIG) Market Segmentation:

Type Outlook (Revenue, USD Billion, 2018 – 2028)

  • IgG
  • IgA
  • IgM
  • IgE
  • IgD

Application Outlook (Revenue, USD Billion, 2018 – 2028)

  • Hypogammaglobulinemia
  • CIPD
  • Immunodeficiency diseases
  • Congenital AIDS
  • Chronic Lymphocytic Leukemia
  • Myasthenia Gravis
  • Multifocal motor neuropathy
  • ITP
  • Kawasaki disease
  • Guillain-Barre syndrome
  • Others

Request a discount on the report @

The report discusses in detail the geographical spread of the market in key regions of the world including North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The report studies the region expected to dominate market growth over the forecast period. The report also talks about the key factors such as supply and demand ratio, production and consumption patterns, consumer demands, technological advancement, research activities, and presence of key players that can influence vital parameters such as market size, market trends, market share, and revenue generation in each region.

Regional analysis covers:

  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of Europe)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report @

The report utilizes advanced analytical tools to research, gather, and analyze data. The in-depth research report has been formulated through extensive primary and secondary research and the data has been further validated and verified from industry experts, professionals, and research analysts. The report also offers strategic recommendations to key market players and novice players to overcome barriers and limitations and gain a robust footing in the market.

Request a customization of the report @

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.

Explore our related report from different Publications:

Needle Free Injection Systems Market @

Cerebral Thrombectomy Systems Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370



Please enter your comment!
Please enter your name here